216 related articles for article (PubMed ID: 17172644)
1. p38 mitogen-activated protein kinase plays an inhibitory role in hepatic lipogenesis.
Xiong Y; Collins QF; An J; Lupo E; Liu HY; Liu D; Robidoux J; Liu Z; Cao W
J Biol Chem; 2007 Feb; 282(7):4975-4982. PubMed ID: 17172644
[TBL] [Abstract][Full Text] [Related]
2. Hepatic PGC-1beta overexpression induces combined hyperlipidemia and modulates the response to PPARalpha activation.
Lelliott CJ; Ljungberg A; Ahnmark A; William-Olsson L; Ekroos K; Elmgren A; Arnerup G; Shoulders CC; Oscarsson J; Lindén D
Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2707-13. PubMed ID: 17932310
[TBL] [Abstract][Full Text] [Related]
3. Retinol binding protein 4 stimulates hepatic sterol regulatory element-binding protein 1 and increases lipogenesis through the peroxisome proliferator-activated receptor-γ coactivator 1β-dependent pathway.
Xia M; Liu Y; Guo H; Wang D; Wang Y; Ling W
Hepatology; 2013 Aug; 58(2):564-75. PubMed ID: 23300015
[TBL] [Abstract][Full Text] [Related]
4. p38 Mitogen-activated protein kinase plays a stimulatory role in hepatic gluconeogenesis.
Cao W; Collins QF; Becker TC; Robidoux J; Lupo EG; Xiong Y; Daniel KW; Floering L; Collins S
J Biol Chem; 2005 Dec; 280(52):42731-7. PubMed ID: 16272151
[TBL] [Abstract][Full Text] [Related]
5. Nectandrin B, a lignan isolated from nutmeg, inhibits liver X receptor-α-induced hepatic lipogenesis through AMP-activated protein kinase activation.
Choi du G; Kim EK; Yang JW; Song JS; Kim YM
Pharmazie; 2015 Nov; 70(11):733-9. PubMed ID: 26790190
[TBL] [Abstract][Full Text] [Related]
6. Fibroblast growth factor-19, a novel factor that inhibits hepatic fatty acid synthesis.
Bhatnagar S; Damron HA; Hillgartner FB
J Biol Chem; 2009 Apr; 284(15):10023-33. PubMed ID: 19233843
[TBL] [Abstract][Full Text] [Related]
7. p38 Mitogen-activated protein kinase mediates free fatty acid-induced gluconeogenesis in hepatocytes.
Collins QF; Xiong Y; Lupo EG; Liu HY; Cao W
J Biol Chem; 2006 Aug; 281(34):24336-44. PubMed ID: 16803882
[TBL] [Abstract][Full Text] [Related]
8. Glucagon regulates hepatic lipid metabolism via cAMP and Insig-2 signaling: implication for the pathogenesis of hypertriglyceridemia and hepatic steatosis.
Wang H; Zhao M; Sud N; Christian P; Shen J; Song Y; Pashaj A; Zhang K; Carr T; Su Q
Sci Rep; 2016 Sep; 6():32246. PubMed ID: 27582413
[TBL] [Abstract][Full Text] [Related]
9. Sterol regulatory element-binding protein-1 as a key transcription factor for nutritional induction of lipogenic enzyme genes.
Shimano H; Yahagi N; Amemiya-Kudo M; Hasty AH; Osuga J; Tamura Y; Shionoiri F; Iizuka Y; Ohashi K; Harada K; Gotoda T; Ishibashi S; Yamada N
J Biol Chem; 1999 Dec; 274(50):35832-9. PubMed ID: 10585467
[TBL] [Abstract][Full Text] [Related]
10. Hepatic glucokinase is required for the synergistic action of ChREBP and SREBP-1c on glycolytic and lipogenic gene expression.
Dentin R; Pégorier JP; Benhamed F; Foufelle F; Ferré P; Fauveau V; Magnuson MA; Girard J; Postic C
J Biol Chem; 2004 May; 279(19):20314-26. PubMed ID: 14985368
[TBL] [Abstract][Full Text] [Related]
11. Coordinated regulation of hepatic FoxO1, PGC-1α and SREBP-1c facilitates insulin action and resistance.
Sajan MP; Lee MC; Foufelle F; Sajan J; Cleland C; Farese RV
Cell Signal; 2018 Mar; 43():62-70. PubMed ID: 29269047
[TBL] [Abstract][Full Text] [Related]
12. Functional interaction of hepatic nuclear factor-4 and peroxisome proliferator-activated receptor-gamma coactivator 1alpha in CYP7A1 regulation is inhibited by a key lipogenic activator, sterol regulatory element-binding protein-1c.
Ponugoti B; Fang S; Kemper JK
Mol Endocrinol; 2007 Nov; 21(11):2698-712. PubMed ID: 17636037
[TBL] [Abstract][Full Text] [Related]
13. Sterol regulatory element binding protein-1c is a major mediator of insulin action on the hepatic expression of glucokinase and lipogenesis-related genes.
Foretz M; Guichard C; Ferré P; Foufelle F
Proc Natl Acad Sci U S A; 1999 Oct; 96(22):12737-42. PubMed ID: 10535992
[TBL] [Abstract][Full Text] [Related]
14. Honokiol activates the LKB1-AMPK signaling pathway and attenuates the lipid accumulation in hepatocytes.
Seo MS; Kim JH; Kim HJ; Chang KC; Park SW
Toxicol Appl Pharmacol; 2015 Apr; 284(2):113-24. PubMed ID: 25737164
[TBL] [Abstract][Full Text] [Related]
15. Betaine attenuates chronic alcohol‑induced fatty liver by broadly regulating hepatic lipid metabolism.
Yang W; Huang L; Gao J; Wen S; Tai Y; Chen M; Huang Z; Liu R; Tang C; Li J
Mol Med Rep; 2017 Oct; 16(4):5225-5234. PubMed ID: 28849079
[TBL] [Abstract][Full Text] [Related]
16. Lipid accumulation stimulates the cap-independent translation of SREBP-1a mRNA by promoting hnRNP A1 binding to its 5'-UTR in a cellular model of hepatic steatosis.
Siculella L; Tocci R; Rochira A; Testini M; Gnoni A; Damiano F
Biochim Biophys Acta; 2016 May; 1861(5):471-81. PubMed ID: 26869449
[TBL] [Abstract][Full Text] [Related]
17. Hepatic lipid metabolic pathways modified by resveratrol in rats fed an obesogenic diet.
Alberdi G; Rodríguez VM; Macarulla MT; Miranda J; Churruca I; Portillo MP
Nutrition; 2013 Mar; 29(3):562-7. PubMed ID: 23274094
[TBL] [Abstract][Full Text] [Related]
18. E4BP4 is an insulin-induced stabilizer of nuclear SREBP-1c and promotes SREBP-1c-mediated lipogenesis.
Tong X; Li P; Zhang D; VanDommelen K; Gupta N; Rui L; Omary MB; Yin L
J Lipid Res; 2016 Jul; 57(7):1219-30. PubMed ID: 27252523
[TBL] [Abstract][Full Text] [Related]
19. Honokiol reverses alcoholic fatty liver by inhibiting the maturation of sterol regulatory element binding protein-1c and the expression of its downstream lipogenesis genes.
Yin HQ; Kim YC; Chung YS; Kim YC; Shin YK; Lee BH
Toxicol Appl Pharmacol; 2009 Apr; 236(1):124-30. PubMed ID: 19371623
[TBL] [Abstract][Full Text] [Related]
20. Liver X receptor mediates hepatitis B virus X protein-induced lipogenesis in hepatitis B virus-associated hepatocellular carcinoma.
Na TY; Shin YK; Roh KJ; Kang SA; Hong I; Oh SJ; Seong JK; Park CK; Choi YL; Lee MO
Hepatology; 2009 Apr; 49(4):1122-31. PubMed ID: 19105208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
